SFA
HAE icon

Sequoia Financial Advisors’s Haemonetics HAE Stock Holding History

Sequoia Financial Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
+4,058
New +$261K ﹤0.01% 1662
2026
Q1 		– Sell
-4,480
Closed -$359K – 1988
2025
Q4 		$359K Buy
+4,480
New +$301K ﹤0.01% 1462

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sequoia Financial Advisors's HAE Position: Q2 2026 in Review

Sequoia Financial Advisors opened a new position in Haemonetics (HAE) in Q2 2026: 4,058 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #1662 among its holdings. This is a return to the name: Sequoia Financial Advisors previously reported a position in HAE as recently as Q4 2025.

Sequoia Financial Advisors first reported a position in HAE in Q4 2025 and has held it in 2 quarters since. The position peaked at $359K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Sequoia Financial Advisors held 4,058 shares of Haemonetics worth $304K as of Q2 2026.
  • Haemonetics was a new Sequoia Financial Advisors position in Q2 2026.
  • Haemonetics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1662 holding.
  • Sequoia Financial Advisors first reported a position in Haemonetics in Q4 2025 and has held it in 2 quarters since.
  • Sequoia Financial Advisors's Haemonetics position peaked at $359K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.